KDR and neoplasm: Indeed, gene ontology and pathway analysis of significantly up and downregulated genes identified hypoxia and glycolysis as two major pathways that were active in cabozantinib-treated tumor cells, indicative of VEGFR2 inhibition (Fig 5C).